FASLG and cancer: Since expression of FASL was restricted mainly to the activated T cell and natural killer cells, it is reasonable to suggest that high level of FASL may create an immune privileged site by killing cytotoxic immune cells and therefore escaping host immune mechanism of protection, thus influencing cancer risk.